Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway
Corinne Bousquet(Centre National de la Recherche Scientifique), Christiane Susini(Inserm), Carole Pichereaux(Centre National de la Recherche Scientifique), Élodie Archer-Lahlou(Inserm), Frédéric Lopez(Centre de Recherche en Cancérologie de Toulouse), Bernard Monsarrat(Institut de Pharmacologie et de Biologie Structurale), Audrey Ferrand(Université Toulouse III - Paul Sabatier), Nathalie Saint‐Laurent(Centre National de la Recherche Scientifique), Marjorie Fanjul(Inserm), Jean‐Pierre Estève(Tulane University), Julie Guillermet‐Guibert(Centre National de la Recherche Scientifique), Daniel Fourmy(Inserm), Lucien Pradayrol(Inserm)
Cited by 84
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
|Science Translational Medicine|2010|335
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
|Nature Communications|2016|287